Clinical Trial Update: Personalized Therapy of Precursor Lymphoid Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on personalized therapy for precursor lymphoid neoplasms; current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Precursor Lymphoid Neoplasms

Snippet

Sponsor: Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice | Conditions: Precursor Lymphoid Neoplasms | Phase 2 | Status: UNKNOWN